newsfilter
← Latest News
GlobeNewswire·

Smart Health Wearables Landmark: UTime Subsidiary Secures 50,000-Unit Mega Order, Opening New Chapter for UTime's Expansion into the North American Market

  • UTime Limited (NASDAQ: WTO) announced a nearly $10 million USD smart health device procurement agreement with Denver-based Tumu Vertex LLC through its Hong Kong subsidiary.
  • The initial order includes 50,000 units comprising 25,000 UT-168 BT Blood Pressure Watches, 25,000 UR08 ECG Smart Rings, 25,000 UT-368 4G Blood Pressure Watches, & 25,000 UR01 Smart Rings.
  • The deal integrates FDA-certified medical-grade monitoring technology with everyday wearable scenarios under FOB Hong Kong delivery terms with phased payments.
  • The first batch of products is scheduled for delivery in Q1 2026 following joint quality control procedures established by both parties.
  • UTime CEO stated the collaboration represents a strategic breakthrough for entering the North American medical-grade wearable market.
  • Tumu Vertex CEO Monil Hossain confirmed the devices will support a US smart health service platform offering 24/7 health monitoring solutions.
  • UTime aims to leverage this order to consolidate its consumer electronics position while expanding its strategic footprint in the medical technology sector.